The Indiana Blood Center said it has been forced to defer up to 30 percent of donors at some post-spring break blood drives because they had traveled to areas where the Zika virus is being transmitted.
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.
An analyst said the delay could be a sign of trouble for the acquisition.
Humana Inc. is set to exit Obamacare markets in at least two states to stem financial losses, another sign of the struggles that health insurers face in the controversial program.
IBJ gathered leaders in the life sciences industry for a Power Breakfast panel discussion April 21. Panel members included Colleen Hittle, managing director of Navigant; Suresh Garimella, Purdue University’s executive vice president of research and partnerships; Brian Barker, general manager of U.S. Seeds for Dow AgroSciences; Kristin Sherman, former chief financial officer of Calibrium LLC; and David Johnson, CEO of BioCrossroads.
Indianapolis-based chemical manufacturer Vertellus Specialties Inc. has expanded its production capacity by 80 percent to keep up with customer demand for DEET, a common active ingredient in mosquito and tick repellents.
During his tenure, Wayne DeVeydt helped Anthem navigate through the recession, make the transition into Obamacare and negotiate its planned $54 billion acquisition of rival Cigna Corp.
It’s the largest recall in recent years for Cook, which previously had issued four recalls covering more than 400,000 catheters and pressuring monitoring sets in the past two years.
PTS Diagnostics, with about 150 employees in Indianapolis, said Monday it has entered a definitive agreement to be acquired by China-based Sinocare Inc.
Drugmaker Pfizer Inc. agreed to pay a total of $785 million to resolve allegations that one of its companies didn't give Medicaid the same discounts it provided to private purchasers of the heartburn treatment Protonix.
Carmel-based Mainstreet Property Group is suing the Indiana State Department of Health in a legal challenge to the state’s new moratorium on nursing homes and transitional care properties.
CNO Financial Group Inc. on Wednesday reported quarterly results that fell short of Wall Street predictions.
Seven insurers, including Indianapolis-based Anthem Inc., reached an agreement with New York Attorney General Eric Schneiderman to cover hepatitis C drugs for patients in the early stages of the disease and for drug and alcohol users.
The company, which is in the process of buying rival insurer Cigna Corp. for $54 billion, said medical enrollment has climbed by about 1 million members since the end of 2015, reaching 39.6 million members.
Lilly got a boost from a stable of new drugs but saw sales tumble for longtime stalwarts Cymbalta and Humalog. Meanwhile, R&D costs rose as the company ushered products through its late-stage pipeline.
Shortages of workers and investment dollars remain the two biggest challenges for Indiana’s life sciences industry, which otherwise is showing robust vital signs and embarking on high-profile collaborations.
Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.
UnitedHealth Group Inc., the biggest U.S. health insurer, said it expects to lose about $650 million on the Obamacare plans this year.
On July 1, Indiana will join 46 states in allowing physicians to write prescriptions after talking to patients on their laptops or smartphones, with no office visit required.
The Carmel-based company has a hired a president and promoted longtime exec Erik Helding to chief financial officer. The company also announced the departure of its chief business officer.
